"Michelle Carnahan spent four years as the president of VC-backed healthcare startup Thirty Madison, and before that, had a two-decade-long career at pharmaceutical giant Eli Lilly. Now, she's launching her own startup without a drop of VC funding. Arbiter, Carnahan's latest venture, has raised $52 million in seed funding at a $400 million valuation, Business Insider has learned exclusively. Instead of turning to VCs, Carnahan raised the round from multiple family offices"
"Arbiter's platform connects patient data to automate administrative tasks on behalf of healthcare providers and health plans, including referrals and appointment scheduling. The healthcare AI startup is only 6 months old, but its tech is already live with over 1,000 clinicians, which Carnahan credits to Arbiter's family office backing. Carnahan has spent most of her career at Big Pharma, including a 26-year stint at Eli Lilly."
Michelle Carnahan launched Arbiter, a healthcare AI startup after four years as president of Thirty Madison and a 26-year career at Eli Lilly. Arbiter raised $52 million in seed funding from multiple family offices at a $400 million valuation, with TriEdge Investments and MFO Ventures co-leading and WindRose Health Investors joining. The platform connects patient data to automate administrative tasks for providers and health plans, including referrals and appointment scheduling. Arbiter reached live deployments with over 1,000 clinicians within six months. Carnahan pursued family office backing to secure specialized healthcare investors who could accelerate market distribution instead of traditional venture capital.
Read at Business Insider
Unable to calculate read time
Collection
[
|
...
]